Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_assertion type Assertion NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_head.
- NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_assertion description "[Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_provenance.
- NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_assertion evidence source_evidence_literature NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_provenance.
- NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_assertion SIO_000772 25510242 NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_provenance.
- NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_assertion wasDerivedFrom befree-2016 NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_provenance.
- NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_assertion wasGeneratedBy ECO_0000203 NP1248183.RA9hMoY9QSZCXo4clh4tVtxF1YSpIJscBpedI-Cu3WTuA130_provenance.